Recombinant Mouse Sphingolipid delta (4)-desaturase DES1 (Degs1)

What is the biological function of DES1 in sphingolipid metabolism and physiological processes?

DES1 is a critical enzyme that catalyzes the last step in de novo sphingolipid synthesis by inserting a conserved double bond at the 4,5 position in the sphingoid base of dihydroceramides, converting them to ceramides. This conversion is essential for ceramide bioactivity, as studies show that dihydroceramides (lacking the double bond) cannot recapitulate many of the biological effects of ceramides .

The enzyme plays significant roles in several physiological processes:

• Metabolic regulation: DES1 influences lipid uptake, storage, and glucose utilization

• Insulin signaling: Ceramides produced by DES1 impair insulin sensitivity

• Hepatic lipid metabolism: DES1 activity affects hepatic steatosis development

• Cancer progression: Supports anchorage-independent survival in tumor cells

Research has demonstrated that genetic ablation of DES1 in mouse models resolves hepatic steatosis and insulin resistance caused by both leptin deficiency and obesogenic diets . This highlights DES1 as a potential therapeutic target for metabolic disorders.

How is recombinant mouse DES1 typically expressed and purified for research applications?

Recombinant mouse DES1 (Degs1) can be produced using various expression systems, with E. coli being the most common for research purposes. The purification process typically involves these steps:

• Gene cloning and vector construction: The Degs1 gene (excluding the signal peptide) is cloned into an appropriate expression vector (e.g., pET series vectors)

• Expression conditions: The protein is expressed in E. coli strains such as BL21(DE3) under optimized conditions to maximize yield while maintaining proper folding

• Purification strategies: A multi-step purification process is employed:

  • Initial clarification of bacterial lysate

  • Affinity chromatography (if tagged versions are used)

  • Ion-exchange chromatography (taking advantage of DES1's isoelectric point)

  • Size-exclusion chromatography for final polishing

• Quality assessment:

  • SDS-PAGE analysis to confirm >85% purity

  • Endotoxin testing to ensure suitability for biological assays

  • Activity testing to confirm functional integrity

The specific approach may be adjusted based on the intended research application, with tagged versions (His-tag, SUMO-tag) often used for easier purification when the tag doesn't interfere with the experimental design .

What are the optimal storage and handling conditions for maintaining recombinant mouse DES1 activity?

To maintain optimal activity and stability of recombinant mouse DES1, researchers should adhere to these evidence-based storage and handling guidelines:

When working with the protein:

• Keep on ice during experiments

• Use appropriate buffer conditions (pH 7.0-7.5)

• Include relevant cofactors if enzymatic activity is being measured

• Consider adding protease inhibitors if used in complex experimental systems

The shelf life of properly stored recombinant DES1 is typically related to multiple factors including buffer composition, storage temperature, and the inherent stability of the protein itself . For quantitative experiments, it is advisable to verify activity before use if the protein has been stored for extended periods.

How can researchers validate the enzymatic activity of recombinant mouse DES1 in experimental systems?

Validating the enzymatic activity of recombinant mouse DES1 requires multiple complementary approaches to ensure functional integrity. Here are methodological approaches with specific protocols:

In vitro enzymatic activity assays:

• Substrate conversion assay:

  • Incubate purified recombinant DES1 (10-50 μg) with dihydroceramide substrates (10-100 μM)

  • Include cofactors: NADPH (1 mM), oxygen, and appropriate buffer system (pH 7.4)

  • Analyze reaction products by LC-MS or HPLC

  • Calculate conversion rates by measuring the ratio of ceramide formed to dihydroceramide substrate

• Comparison with SUMO-VS binding assay:
  Similar to methodologies used for DeSI-1 protein , assess binding specificity:

  • Incubate 0.1 nM recombinant DES1 with 0.5-1 μg SUMO1-VS

  • Analyze adduct formation by SDS-PAGE

  • This approach tests structural integrity of the active site

Cellular validation:

• Reconstitution in DES1-knockout cells:

  • Express recombinant DES1 in CRISPR-generated DES1-knockout cells

  • Measure restoration of ceramide production using lipidomic analysis

  • Quantify ceramide:dihydroceramide ratio as indicator of enzyme activity

• Functional readouts:

  • Assess downstream effects on Akt/PKB phosphorylation

  • Measure impact on cellular glucose uptake

  • Evaluate changes in lipid droplet formation in hepatocytes

Quality control metrics should include dose-dependent activity measurement and comparison to a reference standard to ensure batch-to-batch consistency in activity.

What genetic modification approaches have been successful for studying DES1 function in mouse models?

Several genetic approaches have been successfully implemented to study DES1 function in mouse models, with specific methodological details:

Conditional knockout strategies:

Researchers have generated mice with exon 2 of the Degs1 gene flanked by LoxP sites (floxed) and backcrossed them 10 times onto the C57BL/6 background. These were then bred with mice expressing various Cre recombinases :

• Temporal control: Using tamoxifen-inducible Cre-recombinase inserted into the Rosa26 locus

  • Administration protocol: Tamoxifen (2 mg) injected intraperitoneally for 5 consecutive days

  • Verification: Substantial increase in the proportion of sphingolipids lacking the 4,5 double bond

• Tissue-specific deletion:

  • Adipose-specific: Using adiponectin promoter-driven Cre

  • Liver-specific: AAV-TBG-Cre delivery (adeno-associated virus with thyroid hormone-binding globulin promoter)

  • Intestinal or myeloid cell-specific: Using appropriate tissue-specific Cre lines

RNA interference approaches:

For more acute modulation of DES1 expression:

• shRNA-mediated knockdown:

  • After screening 10 potential shRNA sequences, researchers identified shRNA8 as producing strong Degs1 knockdown

  • Delivery using adeno-associated viruses (AAVs) at two doses:

    • Low dose: 1 × 10¹¹ genome copies/mouse

    • High dose: 3 × 10¹¹ genome copies/mouse

  • This approach substantially reduced liver ceramide levels

CRISPR-based genome editing:

For generating cell lines:

• Guide RNAs targeting human DES1 gene (DEGS1) designed to knockout all three reported transcripts (NM_003676, NM_001321541, NM_001321542)

• Cloned into the Lenticrispr v2.0 plasmid system

• Selection using puromycin (1-2 μg/ml) for 7 days

Each approach offers distinct advantages depending on the research question, with conditional systems allowing for the study of DES1 in adult animals while avoiding the lethality observed with germline ablation.

How does DES1 influence insulin resistance and hepatic steatosis at the molecular level?

DES1 exerts significant influence on insulin resistance and hepatic steatosis through several interconnected molecular mechanisms:

Impact on insulin signaling pathways:

• Akt/PKB activation: Liver-specific ablation of DES1 enhances activation of Akt/PKB in vivo, a critical node in insulin signaling

  • Phosphorylation of Akt is increased in DES1-knockout mice

  • This effect contributes to improved glucose handling

• Lipid-mediated insulin resistance: DES1-derived ceramides impair insulin signaling through:

  • Inhibition of Akt phosphorylation

  • Promotion of protein phosphatase 2A (PP2A) activity

  • Alteration of membrane microdomains essential for insulin receptor signaling

Effects on hepatic lipid metabolism:

• Transcriptional regulation: RNA-seq experiments revealed that DES1 ablation dramatically lowered hepatic expression of sterol regulatory element binding transcription factor 1 (Srebf1)

  • Srebf1 was the most highly down-regulated gene in DES1 knockout animals fed a normal chow diet

  • It ranked sixth most down-regulated in liver-specific DES1 knockout mice maintained on a high-fat diet

• Lipid uptake and storage mechanisms: Mechanistic studies revealed DES1-derived ceramides promote:

  • Increased lipid uptake into hepatocytes

  • Enhanced triglyceride synthesis

  • Reduced fatty acid oxidation

• Physiological outcomes:

  • Decreased liver steatosis

  • Reduced circulating ALT and AST levels (markers of steatohepatitis)

  • Improved glucose tolerance

These molecular effects highlight why DES1 inhibition represents a promising therapeutic strategy for treating metabolic disorders associated with insulin resistance and hepatic steatosis.

What role does DES1 play in cancer progression, particularly in breast cancer models?

DES1 has emerged as a critical factor in cancer progression, with particularly significant roles in breast cancer:

Role in anchorage-independent survival:

Research has identified DES1 as necessary for the acquisition of anchorage-independent survival (AIS), a key cancer-enabling characteristic . Specifically:

• Mechanistic connection: DES1 functions as a downstream effector of HER2-driven glucose uptake and metabolism

  • Links oncogenic metabolism to survival advantage

  • Provides a metabolic bridge between glucose metabolism and sphingolipid synthesis

• Experimental evidence:

  • DES1 is sufficient to drive AIS and in vitro tumorigenicity

  • Increased DES1 levels are found in approximately one-third of HER2+ breast cancers

  • Higher DES1 expression correlates with worse survival outcomes

Methods for studying DES1 in cancer contexts:

• Expression manipulation strategies:

  • Lentiviral vectors for DES1 overexpression in breast cancer cell lines

  • CRISPR-Cas9 for DES1 knockout using guides targeting all three reported transcripts

  • Selection with puromycin (1-2 μg/ml) or blasticidin (10-20 μg/ml) as appropriate

• Functional assays:

  • Soft agar colony formation to assess anchorage-independent growth

  • Anoikis resistance assays using ultra-low attachment plates

  • Glucose uptake and metabolism measurements

Translational significance:

The research demonstrates that targeting DES1 may be an effective approach for overcoming anchorage-independent survival in metastatic breast cancer. This reveals DES1 as both a potential biomarker of aggressive HER2+ breast cancer and a novel therapeutic target.

What analytical methods are most appropriate for sphingolipid profiling in DES1 research?

Sphingolipid profiling is essential in DES1 research to accurately assess the impact of genetic or pharmacological interventions on sphingolipid metabolism. Here are the most appropriate analytical methods with methodological details:

Liquid Chromatography-Mass Spectrometry (LC-MS/MS):

• Sample preparation protocol:

  • Tissue homogenization in appropriate buffer

  • Lipid extraction using Bligh-Dyer or modified Folch method

  • Addition of internal standards (e.g., isotope-labeled ceramides)

  • Reconstitution in LC-compatible solvent

• Analysis parameters:

  • Chromatography: Reverse-phase C18 column with gradient elution

  • MS detection: Multiple reaction monitoring (MRM) for targeted analysis

  • Key analytes: Dihydroceramides, ceramides, sphingomyelins, and glucosylceramides

  • Critical capability: Distinguishing between ceramides and dihydroceramides by mass difference (2 Da)

• Quantification approach:

  • Use isotope-labeled internal standards for each sphingolipid class

  • Calculate ceramide:dihydroceramide ratio as key indicator of DES1 activity

  • Normalize to total protein or phosphate content

Thin-Layer Chromatography (TLC) with radioisotope detection:

For metabolic labeling studies:

• Labeling protocol:

  • Incubate cells with ³H-labeled sphingolipid precursors

  • Extract total lipids and separate by TLC

  • Visualize and quantify by phosphorimaging

• Advantages:

  • Direct visualization of metabolic flux

  • Higher sensitivity for specific pathway analysis

  • Relatively simpler equipment requirements

Immunological detection methods:

For tissue distribution studies:

• Ceramide-specific antibodies:

  • Immunohistochemistry to visualize ceramide accumulation

  • Can be combined with DES1 staining for colocalization analysis

When selecting an analytical method, researchers should consider:

• The sensitivity requirements of their experimental system

• Need for comprehensive profiling vs. targeted analysis

• Equipment availability and expertise

• Sample throughput requirements

The gold standard remains LC-MS/MS due to its superior specificity, sensitivity, and ability to distinguish closely related sphingolipid species.

How does recombinant mouse DES1 differ from other recombinant proteins in terms of experimental design considerations?

Working with recombinant mouse DES1 presents unique experimental considerations compared to other recombinant proteins, requiring specific methodological adaptations:

Membrane protein characteristics:

• Solubility challenges:

  • DES1 is an integral membrane protein with multiple transmembrane domains

  • Requires careful buffer optimization with detergents or lipid environments

  • May benefit from approaches similar to those used for other challenging membrane proteins:

    • Expression as fusion proteins (e.g., SUMO-tag constructs)

    • Refolding protocols similar to those used for TGF-β1

• Activity preservation:

  • Enzymatic function depends on maintaining proper membrane topology

  • Reconstitution in artificial membrane systems may be necessary for optimal activity

Experimental design considerations:

• Controls and standards:

  • Use enzymatically inactive mutants (e.g., histidine to alanine mutations in the catalytic site) as negative controls

  • Include known DES1 inhibitors as reference standards

  • Perform parallel experiments with dihydroceramides and ceramides to distinguish substrate vs. product effects

• Species-specific considerations:

  • Mouse DES1 shares high but not complete homology with human DES1

  • When designing experiments with translational goals, species differences should be acknowledged

  • For cross-species validation, both mouse and human versions may need to be tested in parallel

• Functional assessment approaches:

  • Unlike many secreted proteins that can be directly added to cells, DES1 typically requires cellular expression or specialized delivery methods

  • Consider using transient transfection, viral transduction, or protein delivery systems (liposomes, cell-penetrating peptides)

  • Activity may be highly context-dependent, requiring assessment in appropriate cellular backgrounds

By addressing these specific considerations, researchers can optimize experimental designs to accurately characterize DES1 function while avoiding technical artifacts.

What survey and experimental design tools are most appropriate for DES1 research across multiple model systems?

When designing comprehensive DES1 research programs across multiple model systems, researchers should employ a systematic approach using appropriate survey and experimental design tools:

Survey design for preliminary research:

• Literature analysis frameworks:

  • Systematic reviews following PRISMA guidelines

  • Meta-analyses of DES1 manipulation across model systems

  • Use specialized survey tools like Alchemer for research planning and data collection

• Experimental survey approaches:

  • Screening multiple cell lines for DES1 expression levels using RT-qPCR

  • Tissue expression surveys using immunohistochemistry

  • High-throughput inhibitor screening platforms

Experimental design considerations:

• Multi-model system approach:

  Model System	Advantages	Key Applications
  Cell lines	Molecular mechanism studies	Signaling pathway analysis
  Primary cells	Physiological relevance	Metabolic regulation
  Organ explants	Tissue architecture	Ex vivo drug testing
  Mouse models	Whole-body physiology	Disease modeling
  Patient samples	Clinical relevance	Biomarker validation

• Statistical design principles:

  • Power analysis to determine appropriate sample sizes

  • Factorial designs to analyze interaction effects between DES1 and other factors

  • Randomization and blinding procedures to minimize bias

  • Longitudinal designs for metabolic phenotyping studies

• Specialized design tools:

  • MaxDiff surveys for identifying critical experimental parameters

  • Conjoint analysis for optimizing experimental conditions

  • Semantic differential scales for standardizing phenotype assessments

• Data integration frameworks:

  • Multi-omics approaches combining transcriptomics, proteomics, and lipidomics

  • Network analysis tools to contextualize DES1 within signaling networks

  • Machine learning for pattern recognition across diverse datasets

These approaches should be tailored to specific research questions, with careful consideration of controls, replication, and validation strategies to ensure robust and reproducible findings in DES1 research.

How can researchers effectively troubleshoot inactivity or low activity of recombinant mouse DES1?

When facing challenges with inactivity or low activity of recombinant mouse DES1, researchers should implement a systematic troubleshooting approach:

Protein quality assessment:

• Structural integrity evaluation:

  • SDS-PAGE analysis under both reducing and non-reducing conditions

  • Circular dichroism spectroscopy to assess secondary structure

  • Thermal shift assays to determine protein stability

  • Size-exclusion chromatography to detect aggregation

• Post-translational modification analysis:

  • Mass spectrometry to identify unexpected modifications

  • Phosphorylation status assessment (DES1 activity can be regulated by phosphorylation)

  • Glycosylation profiling if expressed in eukaryotic systems

Assay optimization strategies:

• Buffer composition troubleshooting:

  • Optimize pH (typically 7.0-7.5 for DES1)

  • Test different ionic strengths (50-150 mM NaCl)

  • Evaluate cofactor requirements (NADPH, cytochrome b5)

  • Screen detergent types and concentrations

• Substrate considerations:

  • Ensure substrate purity and proper solubilization

  • Try different dihydroceramide species (varying acyl chain lengths)

  • Consider using fluorescent or radiolabeled substrates for increased sensitivity

• Assay conditions optimization:

  • Test temperature range (25-37°C)

  • Optimize enzyme:substrate ratios

  • Vary reaction time (15 minutes to several hours)

  • Consider adding reducing agents (DTT, β-mercaptoethanol)

Expression system adjustments:

If persistent issues occur, consider switching expression systems:

• Insect cell expression for better membrane protein folding

• Mammalian cell expression for proper post-translational modifications

• Cell-free systems with added microsomes for membrane integration

By systematically addressing these factors, researchers can identify and resolve issues affecting recombinant mouse DES1 activity, ensuring reliable experimental outcomes.

What are the emerging applications of DES1 research beyond metabolic disorders and cancer?

Research on DES1 is expanding beyond its established roles in metabolic disorders and cancer, revealing several promising new applications:

Neurodegenerative disorders:

• Sphingolipid dysregulation in neurodegeneration:

  • DES1-mediated ceramide production impacts neuronal survival

  • Potential role in Alzheimer's and Parkinson's disease pathogenesis

  • Opportunities for neuroprotective interventions through DES1 modulation

• Methodological approaches:

  • Neuron-specific DES1 knockout models

  • Brain sphingolipidomic profiling

  • Cognitive and behavioral testing in DES1-modified models

Immune system regulation:

• T-cell differentiation and function:

  • Comparison with recombinant mouse IL-4 effects (0.3-1.5 ng/mL) on immune cell function

  • DES1-derived ceramides modulate T-cell receptor signaling

  • Influence on Th1/Th2/Th17 balance and inflammatory responses

• Experimental systems:

  • T-cell isolation and culture protocols

  • Cytokine profiling techniques

  • Flow cytometry for immune cell phenotyping

Skin barrier function:

• Connection with desmoglein pathways:

  • Interaction between DES1 and desmosomal proteins like Desmoglein-1-alpha (Dsg1a)

  • Role in maintaining epithelial integrity

  • Implications for inflammatory skin conditions

• Research approaches:

  • Skin-specific DES1 knockout models

  • Trans-epidermal water loss measurements

  • Histological assessment of barrier function

Aging biology:

• Senescence and ceramide accumulation:

  • DES1 activity increases with aging in multiple tissues

  • Potential intervention target for age-related pathologies

  • Connection to cellular senescence mechanisms

• Experimental design considerations:

  • Age-dependent expression profiling

  • Lifespan studies in DES1-modulated models

  • Integration with other aging pathways